MGC Pharmaceuticals Limited
MGCLF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $2 | $5 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $2 | $1 |
| Inventory | $1 | $2 | $1 | $0 |
| Other Curr. Assets | $0 | $1 | $1 | $0 |
| Total Curr. Assets | $3 | $6 | $9 | $3 |
| Property Plant & Equip (Net) | $7 | $9 | $7 | $4 |
| Goodwill | $0 | $3 | $7 | $7 |
| Intangibles | $0 | $3 | $7 | $7 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $9 | $8 | -$15 |
| Other NC Assets | -$7 | -$12 | -$15 | $1 |
| Total NC Assets | $7 | $12 | $15 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $19 | $24 | $8 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $1 | $2 |
| Short-Term Debt | $9 | $2 | $4 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $2 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $1 |
| Total Curr. Liab. | $13 | $8 | $6 | $3 |
| LT Debt | $0 | $2 | $2 | $2 |
| Deferred Rev, NC | $4 | $4 | $3 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $5 | $6 | $4 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $18 | $13 | $10 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $104 | $97 | $85 | $60 |
| Retained Earnings | -$119 | -$98 | -$78 | -$62 |
| AOCI | $8 | $7 | $7 | $5 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$7 | $6 | $14 | $3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $10 | $19 | $24 | $8 |
| Net Debt | $10 | $2 | $1 | $0 |